NYSE:TDOCTeladoc Health Stock Price, Forecast & News

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TDOC stock has increased by 14.4% and is now trading at $157.15. View which stocks have been most impacted by Coronavirus.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Teladoc Health.

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Teladoc Health.

Teladoc Health Inc (NYSE:TDOC) announced its quarterly earnings results on Wednesday, April, 29th. The health services provider reported ($0.40) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by $0.05. The health services provider earned $180.80 million during the quarter, compared to analysts' expectations of $180.64 million. Teladoc Health had a negative net margin of 16.24% and a negative return on equity of 10.60%. The business's quarterly revenue was up 40.6% on a year-over-year basis. During the same period last year, the business earned ($0.43) earnings per share. View Teladoc Health's earnings history.

Teladoc Health issued an update on its second quarter 2020 After-Hours earnings guidance on Wednesday, April, 29th. The company provided earnings per share (EPS) guidance of -0.28--0.23 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.3. The company issued revenue guidance of $215-225 million, compared to the consensus revenue estimate of $182.26 million.

24 equities research analysts have issued 1-year target prices for Teladoc Health's shares. Their forecasts range from $80.00 to $212.00. On average, they expect Teladoc Health's share price to reach $160.83 in the next year. This suggests a possible upside of 2.3% from the stock's current price. View analysts' price targets for Teladoc Health.

Media stories about TDOC stock have trended negative recently, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Teladoc Health earned a media sentiment score of -2.7 on InfoTrie's scale. They also gave news headlines about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutTeladoc Health.

Some companies that are related to Teladoc Health include Edwards Lifesciences (EW), Baxter International (BAX), Siemens Healthineers (SHL), Centene (CNC), RESMED/IDR UNRESTR (RMD), LONZA GRP AG/ADR (LZAGY), HCA Healthcare (HCA), DexCom (DXCM), COLOPLAST A/S/ADR (CLPBY), ASTELLAS PHARMA/ADR (ALPMY), TERUMO CORP/ADR (TRUMY), ESSILOR INTL S/S (ESLOY), Actelion (ALIOF), McKesson (MCK) and FRESENIUS SE &/S (FSNUY). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Shopify (SHOP), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS), Trade Desk (TTD), Square (SQ), salesforce.com (CRM) and Paypal (PYPL).

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Teladoc Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (7.76%), Waddell & Reed Financial Inc. (2.27%), State Street Corp (2.00%), Alliancebernstein L.P. (1.93%), Ensign Peak Advisors Inc (1.92%) and Capital World Investors (1.89%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Gabriel R Cappucci, Jason N Gorevic, Lewis Levy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen and Stephany Verstraete. View institutional ownership trends for Teladoc Health.

TDOC stock was sold by a variety of institutional investors in the last quarter, including BNP Paribas Arbitrage SA, Zurcher Kantonalbank Zurich Cantonalbank, Champlain Investment Partners LLC, Alliancebernstein L.P., Waddell & Reed Financial Inc., Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., and Nikko Asset Management Americas Inc.. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Gabriel R Cappucci, Jason N Gorevic, Lewis Levy, Michael Goldstein, Peter A Mcclennen, and Stephany Verstraete. View insider buying and selling activity for Teladoc Health.

TDOC stock was bought by a variety of institutional investors in the last quarter, including Capital World Investors, Fred Alger Management LLC, FDx Advisors Inc., AGF Investments Inc., Gunderson Capital Management Inc., Nuveen Asset Management LLC, Geode Capital Management LLC, and Capital Advisors Inc. OK. View insider buying and selling activity for Teladoc Health.

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TDOC stock can currently be purchased for approximately $157.15.

Teladoc Health has a market capitalization of $11.70 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

The official website for Teladoc Health is www.teladoc.com.

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]